| Correction of geographical distribution in C-RAD ABs Interim report January-June 2018 In C-RADs Interim Report for January – June, 2018 it has been identified that the figures in a graph of the geographical distribution of order intake for the second quarter of 2018 are incorrect. The correct change of order intake in the second quarter 2018 for respective region is: US -24% instead of -31% EMEA +13% instead of +2% APAC +115% instead of +90% This correction does not have any effect on any other published information. The updated Interim Report is attached. |
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 09:45 CEST on August 21, 2018.
Attachments
